(Q54743924)

3 June 2018

title

Survivin Expression in Atypical Adenomatous Hyperplasia of the Lung (English)

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

30 March 2024

author name string

Kuniaki Nakanishi

1

1 reference

3 June 2018

Toshiaki Kawai

2

1 reference

3 June 2018

Fumiyuki Kumaki

3

1 reference

3 June 2018

Sadayuki Hiroi

4

1 reference

3 June 2018

Makio Mukai

5

1 reference

3 June 2018

Eiji Ikeda

6

1 reference

3 June 2018

American Journal of Clinical Pathology

language of work or name

English

1 reference

inferred from

publication date

1 November 2003

1 reference

3 June 2018

American Journal of Clinical Pathology

published in

1 reference

3 June 2018

volume

120

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

712-719

1 reference

3 June 2018

Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen

cites work

1

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Argyrophilic nucleolar-organizer region counts and DNA status in bronchioloalveolar epithelial hyperplasia and adenocarcinoma of the lung

30 March 2024

3

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

30 March 2024

5

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

30 March 2024

6

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of survivin and Bcl-2 in the normal human endometrium

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia

30 March 2024

13

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Apoptosis in the pathogenesis and treatment of disease

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Control of programmed cell death by the baculovirus genes p35 and iap.

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of p53 and CEA in Atypical Adenomatous Hyperplasia of the Lung

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

The proto-oncogene Bcl-2 and its role in regulating apoptosis

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

bcl-2: role in epithelial differentiation and oncogenesis

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

bcl-2 protein in non-small-cell lung carcinoma

30 March 2024

25

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Human IAP-Like Protein Regulates Programmed Cell Death Downstream of Bcl-xL and Cytochrome c

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma

30 March 2024

29

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of cyclin D1, retinoblastoma gene protein, and p16 MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Wild-type p53 can down-modulate the activity of various promoters

30 March 2024

34

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Monoclonality of atypical adenomatous hyperplasia of the lung

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma

30 March 2024

38

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung

30 March 2024

39

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

X-linked IAP is a direct inhibitor of cell-death proteases

30 March 2024

40

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa

30 March 2024

48

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

p53 alterations in atypical alveolar hyperplasia of the human lung

30 March 2024

50

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

Comparative ultrastructural study of atypical adenomatous hyperplasia and adenocarcinoma of the human lung

30 March 2024

51

1 reference

https://api.crossref.org/works/10.1309/GWTN-2JTA-N6K7-3YDE

30 March 2024

Identifiers

1 reference

3 June 2018

1 reference

3 June 2018